Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.49 - $7.2 $511,860 - $820,800
-114,000 Reduced 50.18%
113,200 $670,000
Q2 2024

Aug 15, 2024

BUY
$4.33 - $6.79 $612,262 - $960,106
141,400 Added 164.8%
227,200 $1.11 Million
Q1 2024

May 07, 2024

BUY
$4.03 - $7.81 $227,695 - $441,265
56,500 Added 192.83%
85,800 $615,000
Q4 2023

Feb 14, 2024

BUY
$1.63 - $4.63 $21,516 - $61,116
13,200 Added 81.99%
29,300 $133,000
Q3 2023

Nov 14, 2023

SELL
$2.13 - $3.84 $253,896 - $457,728
-119,200 Reduced 88.1%
16,100 $37,000
Q2 2023

Aug 11, 2023

BUY
$2.1 - $6.37 $284,130 - $861,861
135,300 New
135,300 $476,000
Q4 2022

Feb 14, 2023

BUY
$4.56 - $6.61 $9,576 - $13,881
2,100 Added 1.03%
206,900 $1.07 Million
Q3 2022

Nov 14, 2022

BUY
$3.75 - $6.63 $425,250 - $751,842
113,400 Added 124.07%
204,800 $1.27 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $249M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.